Cargando…
Impact of Biologics on SARS-COV-2 Disease Course When Infused Within 2 Weeks of Acquiring the Infection Among IBD Patients
SARS-CoV-2 was first identified in Wuhan in December 2019 and since then it has progressed into a pandemic that evolves continuously.(1) As of May 5, 2022, there have been more than 81 million cases and 994,187 deaths in the United States.(2) Inflammatory bowel disease (IBD) is a chronic inflammator...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
W.B. Saunders for the American Gastroenterological Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404074/ https://www.ncbi.nlm.nih.gov/pubmed/36029967 http://dx.doi.org/10.1016/j.cgh.2022.08.017 |